Positron emission tomography scans in postchemotherapy seminoma patients with residual masses: a retrospective review from Indiana University Hospital von Lewis, DeQuincy A, Tann, Mark, Kesler, Kenneth, McCool, Alan, Foster, Richard S, Einhorn, Lawrence H

Volltext

Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Cl... von Meyerhardt, Jeffrey A, Shi, Qian, Fuchs, Charles S, Meyer, Jeffrey, Niedzwiecki, Donna, Zemla, Tyler, Kumthekar, Priya, Guthrie, Katherine A, Couture, Felix, Kuebler, Philip, Bendell, Johanna C, Kumar, Pankaj, Lewis, Dequincy, Tan, Benjamin, Bertagnolli, Monica, Grothey, Axel, Hochster, Howard S, Goldberg, Richard M, Venook, Alan, Blanke, Charles, O’Reilly, Eileen M, Shields, Anthony F

Volltext

Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702 von Lee, Seohyuk, Ma, Chao, Shi, Qian, Kumar, Pankaj, Couture, Felix, Kuebler, Philip, Krishnamurthi, Smitha, Lewis, DeQuincy, Tan, Benjamin, Goldberg, Richard M, Venook, Alan, Blanke, Charles, O'Reilly, Eileen M, Shields, Anthony F, Meyerhardt, Jeffrey A

Volltext

Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance) von Brown, Justin C, Ma, Chao, Shi, Qian, Fuchs, Charles S, Meyer, Jeffrey, Niedzwiecki, Donna, Zemla, Tyler, Couture, Felix, Kuebler, Philip, Kumar, Pankaj, Lewis, DeQuincy, Tan, Benjamin, Krishnamurthi, Smitha, O'Reilly, Eileen M, Shields, Anthony F, Meyerhardt, Jeffrey A

Volltext

Sleep and cancer recurrence and survival in patients with resected Stage III colon cancer: findings from CALGB/SWOG 80702 (Alliance) von Lee, Seohyuk, Ma, Chao, Shi, Qian, Meyers, Jeffrey, Kumar, Pankaj, Couture, Felix, Kuebler, Philip, Krishnamurthi, Smitha, Lewis, DeQuincy, Tan, Benjamin, O’Reilly, Eileen M., Shields, Anthony F., Meyerhardt, Jeffrey A.

Volltext

Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes von Skerget, Sheri, Penaherrera, Daniel, Chari, Ajai, Jagannath, Sundar, Siegel, David S., Vij, Ravi, Orloff, Gregory, Jakubowiak, Andrzej, Niesvizky, Ruben, Liles, Darla, Berdeja, Jesus, Levy, Moshe, Wolf, Jeffrey, Usmani, Saad Z., Christofferson, Austin W., Nasser, Sara, Aldrich, Jessica L., Legendre, Christophe, Benard, Brooks, Miller, Chase, Turner, Bryce, Kurdoglu, Ahmet, Washington, Megan, Yellapantula, Venkata, Adkins, Jonathan R., Cuyugan, Lori, Boateng, Martin, Helland, Adrienne, Kyman, Shari, McDonald, Jackie, Reiman, Rebecca, Stephenson, Kristi, Tassone, Erica, Blanski, Alex, Livermore, Brianne, Kirchhoff, Meghan, Rohrer, Daniel C., D’Agostino, Mattia, Gamella, Manuela, Collison, Kimberly, Stumph, Jennifer, Kidd, Pam, Donnelly, Andrea, Zaugg, Barbara, Toone, Maureen, McBride, Kyle, DeRome, Mary, Rogers, Jennifer, Craig, David, Liang, Winnie S., Gutierrez, Norma C., Jewell, Scott D., Carpten, John, Anderson, Kenneth C., Cho, Hearn Jay, Auclair, Daniel, Lonial, Sagar, Keats, Jonathan J.

Volltext

Randomized phase II clinical trial of cisplatin/carboplatin and etoposide (CE) alone or in combination with nivolumab as frontline therapy for extensive-stage small cell lung cance... von Leal, Ticiana, Wang, Yating, Dowlati, Afshin, Lewis, DeQuincy Andrew, Chen, Yuanbin, Mohindra, Amit Ramesh, Razaq, Mohammad, Ahuja, Harish G., Liu, Jijun, King, David M., Sumey, Christopher Joseph, Ramalingam, Suresh S.

Volltext

Prognostic value of tumor deposits in stage III colon cancer patients, a post-hoc analysis of CALGB/SWOG 80702 phase III study von Cohen, Romain, Shi, Qian, Meyers, Jeffrey P., Jin, Zhaohui, Svrcek, Magali, Fuchs, Charles S., Couture, Felix, Kuebler, J. Phillip, Bendell, Johanna C., De Jesus-Acosta, Ana, Kumar, Pankaj, Lewis, DeQuincy Andrew, Tan, Benjamin R., Bertagnolli, Monica M., Hochster, Howard S., Blanke, Charles David, O'Reilly, Eileen Mary, Shields, Anthony Frank, Meyerhardt, Jeffrey A.

Volltext

Randomized phase III trial of eribulin (E) versus standard weekly paclitaxel (P) as first- or second-line therapy for locally recurrent or metastatic breast cancer (MBC) von Liu, Minetta C., Hillman, David W., Frith, Ashley Elizabeth, Lyss, Alan P., Weckstein, Douglas Jay, Moreno-Aspitia, Alvaro, Le-Lindqwister, Nguyet, Isaacs, Claudine, Wender, Donald B., Lewis, DeQuincy Andrew, Cole, John T., Jaslowski, Anthony John, Rowland, Kendrith M., Openshaw, Thomas H., Friday, Bret Edward Buckley, Fleming, Gini F., Asmus, Erik, Rogak, Lauren J., Basch, Ethan M., Dueck, Amylou C.

Volltext

Celecoxib in addition to standard adjuvant therapy with 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) in stage III colon cancer: Results from CALGB/SWOG 80702 von Meyerhardt, Jeffrey A., Shi, Qian, Fuchs, Charles S., Niedzwiecki, Donna, Zemla, Tyler J., Kumthekar, Priya, Guthrie, Katherine A, Couture, Felix, Kuebler, J. Phillip, Bendell, Johanna C., Kumar, Pankaj, Lewis, DeQuincy Andrew, Tan, Benjamin R., Bertagnolli, Monica M., Grothey, Axel, Hochster, Howard S., Goldberg, Richard M., Venook, Alan P., Blanke, Charles David, Shields, Anthony Frank

Volltext

Abstract 682: Associations of inflammatory biomarkers with survival among patients with stage III colon cancer (CALGB/SWOG 80702 [Alliance]) von Cheng, En, Qian, Shi, Shields, Anthony F., Feliciano, Elizabeth M. Cespedes, Nixon, Andrew B., Shergill, Ardaman P., Guthrie, Katherine A., Couture, Felix, Kuebler, Philip, Kumar, Pankaj, Lewis, Dequincy, Tan, Benjamin, O'Reilly, Eileen M., Brown, Justin C., Philip, Philip A., Caan, Bette J., Meyerhardt, Jeffrey A.

Volltext